Evidence map›Paper›PMID 32711409›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2020

Toxicity of Saffron Extracts on Cancer and Normal Cells: A Review Article.

Masihollah Shakeri, Akbar Hashemi Tayer, Heshmatollah Shakeri, Abdolreza Sotoodeh Jahromi, Malihe Moradzadeh, Mohammad Hojjat-Farsangi

Open access · goldAbstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Eco-Friendly SpeciesACS omega · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Molecules (Basel, Switzerland) · 2021
    Article
  18. Article
  19. Article
  20. Safranal Inhibits AngiogenesisFrontiers in oncology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Masihollah ShakeriResearch Center for Non-Communicable Disease, Jahrom University of Medical Sciences, Jahrom, Iran.
Akbar Hashemi TayerResearch Center for Non-Communicable Disease, Jahrom University of Medical Sciences, Jahrom, Iran.
Heshmatollah ShakeriResearch Center for Non-Communicable Disease, Jahrom University of Medical Sciences, Jahrom, Iran.
Abdolreza Sotoodeh JahromiResearch Center for Non-Communicable Disease, Jahrom University of Medical Sciences, Jahrom, Iran.ORCID 0000-0002-2131-2113
Malihe MoradzadehGolestan Rheumatology Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Mohammad Hojjat-FarsangiDepartment of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden.
Jahrom University of Medical Sciences · IRGolestan University of Medical Sciences · IRKarolinska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimMedicinal plants have played an important role in human health since the Stone Age. According to WHO, 80% of Asian and African people rely on traditional medicine and medicinal plants to conserve their health. Saffron has received much attention among the herbal compounds related to cancer treatment.

methodsThis review aims to provide an overview of in-vitro and in-vivo evaluation molecule mechanism for anti-tumor activity, cancer preventing and protective effects of saffron extract. The review is based on the available data accessible in PubMed, Science Direct, Google Scholar, Magiran.ir, and SID.ir databases.

resultsSaffron has selective toxic and preventive effects on cancerous cells and without adverse effects on normal cells and prevents tumor formation. Saffron appears to reduce the toxic effects of anticancer drugs. Saffron has toxicity effects when used in high amounts, which are far greater than those  are used in human food culture.

conclusionsConsidering the observed effects of saffron on the removal of cancer cells, saffron extract can be used in the treatment and prevention of cancer after confirmation in human clinical trials. According to the high IC50 of saffron extracts in normal cells, its toxicity against non-cancerous cells is low and its use is safe. Besides, the studies suggested the cytotoxic effects of saffron on some of the  more cancers, including nervous system cancer and common cancers. Further studies are required to determine the effective dose and influence of mechanism of saffron in various animal type of cancers.

Indexed as

PhytotherapyAnimalsAntineoplastic AgentsCrocusHumansNeoplasmsPlant ExtractsAntineoplastic AgentsPlant ExtractscancerCytotoxicitySaffron Extract

Identifiers

PMID32711409
PMCPMC7573418
OpenAlexW3044639570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.